Bottom line
EIHSX vs IXJ: the short answer
EIHSX (Eaton Vance Worldwide Health Sciences Fund) and IXJ (iShares Global Healthcare ETF) are both mutual funds.
But IXJ is far broader, holding 124 positions to 42 for EIHSX, so beyond the top names it adds exposure EIHSX doesn't have.
IXJ is cheaper at 0.38% vs 0.93% — a difference of $55 a year per $10,000 invested.
Over five years, EIHSX returned +6.7% a year vs +6.4% for IXJ (reporting dates differ).
Updated Nov 19, 2026
EIHSX vs IXJ side by side
| EIHSX | IXJ | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Morgan Stanley | iShares |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.93% | 0.38% |
| Annual cost per $10k | $93 | $38 |
| 10-yr cost on $10k (prospectus) | $1,175 | $480 |
| Max front load | 0% | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +3.7% | +14.9% |
| 5-yr return (annualized) | +6.7% | +6.4% |
| 10-yr return (annualized) | +7.2% | +8.2% |
| Best quarter | — | +13.6% |
| Worst quarter | — | −11.8% |
| Net assets (fund) | $757.9M | $3.8B |
| Number of holdings | 42 | 124 |
| Portfolio turnover | 3% | 2% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
17 of EIHSX's top 25 holdings also appear in IXJ's top 25.
| Holding | EIHSX | IXJ |
|---|---|---|
| Eli Lilly & Co | 12.47% | 10.93% |
| AbbVie Inc | 6.46% | 5.12% |
| Johnson & Johnson | 6.45% | 7.04% |
| AstraZeneca PLC | 6.24% | 3.76% |
| UnitedHealth Group Inc | 5.49% | 4.40% |
| Roche Holding AG | 5.44% | 3.75% |
| Merck & Co Inc | 5.08% | 4.12% |
| Bristol-Myers Squibb Co | 4.25% | 1.53% |
| Vertex Pharmaceuticals Inc | 3.38% | 1.64% |
| Gilead Sciences Inc | 3.34% | 2.04% |
| Sanofi SA | 2.95% | 1.18% |
| Thermo Fisher Scientific Inc | 2.79% | 2.42% |
| Intuitive Surgical Inc | 2.72% | 1.83% |
| Stryker Corp | 2.21% | 1.41% |
| Novo Nordisk A/S | 1.71% | 1.99% |
Source: SEC Form N-PORT
EIHSX top 10
- Eli Lilly & Co — 12.47%
- AbbVie Inc — 6.46%
- Johnson & Johnson — 6.45%
- AstraZeneca PLC — 6.24%
- UnitedHealth Group Inc — 5.49%
- Roche Holding AG — 5.44%
- Merck & Co Inc — 5.08%
- Bristol-Myers Squibb Co — 4.25%
- Vertex Pharmaceuticals Inc — 3.38%
- Gilead Sciences Inc — 3.34%
IXJ top 10
- Eli Lilly And Company — 10.93%
- Johnson & Johnson — 7.04%
- Abbvie Inc. — 5.12%
- Unitedhealth Group Incorporated — 4.40%
- Merck & Co., Inc. — 4.12%
- Astrazeneca Plc — 3.76%
- Roche Holding AG — 3.75%
- Novartis AG — 3.71%
- Amgen Inc. — 2.54%
- Thermo Fisher Scientific Incorporated — 2.42%
FAQ
What is the difference between EIHSX and IXJ?
Which is cheaper, EIHSX or IXJ?
Should I own both EIHSX and IXJ?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.